Transcatheter aortic valve implantation with or without on-site cardiac surgery
Official title: TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial
Run by Azienda Usl di Bologna · NCT05751577 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing whether getting a heart valve replacement without immediate access to heart surgery is as safe and effective as having it done where surgery is available for patients needing this treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 566 (estimated) |
| Sponsor | Azienda Usl di Bologna Government |
| Locations | 9 sites (Arezzo and 8 other locations) |
| Trial ID | NCT05751577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with severe aortic stenosis who are either inoperable or at high surgical risk as determined by the Heart Team.
✕Probably not a fit
Patients unsuitable for transfemoral TAVI or those requiring emergent procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The TRACS trial aims to compare the outcomes of transcatheter aortic valve implantation (TAVI) performed in centers without on-site cardiac surgery to those performed in centers with on-site surgery. This multicenter, randomized trial will involve experienced operators and will assess all-cause death, stroke, and rehospitalization for cardiovascular causes. Patients will be recruited based on a Heart Team's indication for TAVI, and their eligibility will be confirmed by a unanimous decision of the team. Participants will be randomized in a 2:1 ratio to receive TAVI in either setting.
Why it matters
Potential benefit: If successful, this study could provide a safe and effective option for patients with severe aortic stenosis who are at high surgical risk.
How similar studies have gone: Other studies have shown promising results with TAVI procedures, but this specific comparison of settings is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Severe aortic stenosis * Indication to TAVI confirmed by the Study Heart Team AND one of the following: * Inoperable due to prohibitive operative risk * High surgical risk as defined as STS score \>8% The presence of at least one clinical factor that, by unanimous judgment of the Study Heart Team, compromises the benefit/risk ratio in the case of emergent cardiac surgery: * Porcelain aorta or severely atherosclerotic aorta * Frailty/Reduced physical performance * Cognitive impairment, dementia, or Parkinson's disease * Severe liver disease/cirrhosis * Hostile chest * Internal mammalian artery or other critical conduit(s) crossing midline and/or adhering to the posterior table of the sternum * Severe pulmonary hypertension and/or severe right ventricular dysfunction * Severe Chronic Obstructive Pulmonary Disease (COPD) * Age ≥85 years Exclusion Criteria: * Unsuitable for transfemoral TAVI * Emergent TAVI * Noncardiovascular comorbidity reducing life expectancy to \<1 year * Any factor precluding 1-year follow-up * Refusal informed consent
Where it's running
-
Ospedale San Donato di Arezzo
Arezzo, Italy Recruiting -
Ospedale Cardinal Massaia di Asti
Asti, Italy Recruiting -
Ospedale degli Infermi di Biella
Biella, Italy Recruiting -
Azienda Unità Sanitaria Locale
Bologna, Italy Recruiting -
Azienda Ospedaliero Universitaria di Ferrara
Ferrara, Italy Recruiting -
Ospedale Misericordia di Grosseto
Grosseto, Italy Recruiting
Show 3 more locations
-
Azienda ULSS 3 Serenissima, Ospedale di Mirano
Mirano, Italy Recruiting -
Ospedale Guglielmo da Saliceto di Piacenza
Piacenza, Italy Recruiting -
Azienda Ospedaliera di Reggio Emilia
Reggio Emilia, Italy Recruiting
Study contacts
- Study coordinator: Gianmarco Iannopollo, Md
- Email: gianmarco.iannopollo@ausl.bologna.it
- Phone: 0513138704
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging data collection for patients undergoing Transcatheter Aortic Valve Implantation
This study is collecting imaging data from patients with severe aortic stenosis who are getting a new heart valve to see if these scans can help predict how well the valve will work in the future.
-
Using lung ultrasound to improve outcomes in cardiac surgery patients
This study is testing if using lung ultrasound can help doctors find lung problems earlier in patients after heart surgery compared to regular X-rays and CT scans.
-
Exercise testing using cardiac MRI for patients with severe aortic stenosis
This study is testing how patients with severe aortic stenosis respond to exercise using advanced heart imaging to help doctors make better treatment choices before they get a heart valve replacement.
-
SAPIEN X4 Transcatheter Heart Valve safety and effectiveness in severe aortic stenosis
This study tests the safety and effectiveness of the Edwards SAPIEN X4/X4S transcatheter heart valve in patients with symptomatic, severe aortic stenosis.
-
Aortic valve replacement using SAPIEN 3 for failing bioprosthetic valves
This study is testing if the SAPIEN 3 heart valves can safely help patients with failing bioprosthetic aortic valves feel better.
-
Registry of Transcatheter Aortic Valve Treatments at a Italian Center
This registry tests how safe and effective transcatheter valve procedures are in adults with severe aortic stenosis treated at a single Italian center.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.